Breast Cancer Clinical Trials in Maastricht
6 recruitingMaastricht, Netherlands
Showing 1–6 of 6 trials
Recruiting
Phase 3
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
Breast Cancer
Daiichi Sankyo250 enrolled86 locationsNCT05950945
Recruiting
Phase 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Breast CancerEsophageal CancerGastric Cancer+11 more
Daiichi Sankyo740 enrolled84 locationsNCT06172478
Recruiting
TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer
Breast Cancer
The Netherlands Cancer Institute100 enrolled6 locationsNCT06931769
Recruiting
Phase 2
18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.
Breast CancerBreast NeoplasmsBreast Diseases
Maastricht University Medical Center20 enrolled1 locationNCT06335069
Recruiting
Developing Breast (Cancer) Organoids
Breast Cancer
Maastricht Radiation Oncology60 enrolled1 locationNCT05317221
Recruiting
Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
Breast CancerNeoadjuvant TherapyLymph Node Metastases
Maastricht University Medical Center549 enrolled35 locationsNCT04486495